|
Q4 2018
Filed on Feb 14, 2019
|
700
|
$22.95 - $43.78
$16.1K - $30.6K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
151
|
$16.38 - $20.14
$2.47K - $3.04K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
200
|
$2.4 - $4.29
$480 - $858
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,340
|
$64.9 - $98.8
$87K - $132K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
598
|
$54.89 - $60.77
$32.8K - $36.3K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100
|
$2.58 - $4.09
$258 - $409
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
230
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
29
|
$50.97 - $55.23
$1.48K - $1.6K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
200
|
$28.45 - $40.65
$5.69K - $8.13K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
150
|
$42.88 - $83.72
$6.43K - $12.6K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100
|
$4.22 - $10.74
$422 - $1.07K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
2
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
15
|
$109.81 - $128.79
$1.65K - $1.93K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
400
|
$25.9 - $65.93
$10.4K - $26.4K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1
|
$85.47 - $93.46
$85.5 - $93.5
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
78
|
$124.17 - $163.24
$9.69K - $12.7K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
30
|
$31.49 - $48.83
$945 - $1.46K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100
|
$49.39 - $84.03
$4.94K - $8.4K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
85
|
N/A
|
|
Invesco Exchng Traded Fd Tr
|
Q4 2018
Filed on Feb 14, 2019
|
28
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
948
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
4
|
$18.31 - $22.16
$73.2 - $88.6
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
5,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
700
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100
|
$5.45 - $8.54
$545 - $854
|
|
Alder Biopharmaceuticals Inc
|
Q4 2018
Filed on Feb 14, 2019
|
200
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100
|
$10.57 - $19.29
$1.06K - $1.93K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
4,300
|
$18.17 - $20.59
$78.1K - $88.5K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
100
|
$16.08 - $21.85
$1.61K - $2.19K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
59
|
$14.95 - $17.29
$882 - $1.02K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
200
|
$27.0 - $42.48
$5.4K - $8.5K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
508
|
$23.57 - $32.33
$12K - $16.4K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
206
|
$50.03 - $65.39
$10.3K - $13.5K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
2,775
|
$45.74 - $60.45
$127K - $168K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,188
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,600
|
$36.92 - $49.23
$59.1K - $78.8K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
13
|
$35.84 - $51.55
$466 - $670
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
31
|
$55.94 - $68.65
$1.73K - $2.13K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
61
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
2,918
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1
|
$35.81 - $43.71
$35.8 - $43.7
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
600
|
$91.38 - $122.12
$54.8K - $73.3K
|
|
Fiduciary Claymore Mlp Opp F
|
Q4 2018
Filed on Feb 14, 2019
|
5,100
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
957
|
$76.83 - $105.99
$73.5K - $101K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
779
|
$78.5 - $118.47
$61.2K - $92.3K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
380
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
300
|
$72.34 - $101.62
$21.7K - $30.5K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
12
|
$141.11 - $185.4
$1.69K - $2.22K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
3,728
|
$60.54 - $79.0
$226K - $295K
|
|